|
2021
|
P/S
|
medical, veterinary, and scientific research, namely, conducting clinical trials; medical, veteri... |
|
2020
|
Invention
|
T cell repertoire dynamics and oncolytic viral therapy.
Provided herein are methods of treating ... |
|
|
Invention
|
T cell repertoire dynamics and oncolytic viral therapy. Provided herein are methods of treating c... |
|
|
Invention
|
Reoviruses having modified sequences. The invention provides for modified reovirus nucleic acid s... |
|
2018
|
P/S
|
Pharmaceutical products; pharmaceuticals for the treatment of cancer; pharmaceutical preparations... |
|
2015
|
Invention
|
Liquid viral formulations. Provided herein are liquid viral formulations useful for the stabiliza... |
|
|
Invention
|
Lyophilized viral formulations. Provided herein are lyophilized viral formulations useful for the... |
|
2014
|
Invention
|
Oncolytic viruses and increased cancer treatment regimens.
Provided herein is a method of treati... |
|
|
Invention
|
Oncolytic viruses and increased cancer treatment regimens. Provided herein is a method of treatin... |
|
|
Invention
|
Methods of treating taxane naïve subjects with primary tumors or with metastatic cancer. Provided... |
|
|
P/S
|
Housemark for pharmaceutical products; pharmaceutical preparations for use in the treatment of ca... |
|
|
P/S
|
Medical and scientific research, namely, conducting clinical trials; medical and scientific resea... |
|
|
Invention
|
Viral purification methods. The present invention is directed to an improved method of purifying ... |
|
2013
|
Invention
|
Virus clearance of neoplastic cells from mixed cellular compositions. The present invention relat... |
|
|
Invention
|
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy.
Provided herei... |
|
|
Invention
|
Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein. Prov... |
|
2012
|
Invention
|
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus. The present inve... |
|
|
Invention
|
Methods of purifying viruses using gel permeation chromatography. Provided herein are elution buf... |
|
|
Invention
|
Methods of purifying viruses using gel permeation chromatography.
Provided herein are elution bu... |
|
|
Invention
|
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions. Reovirus ca... |
|
2011
|
Invention
|
Viruses for the treatment of cellular proliferative disorders. Methods for treating cell prolifer... |
|
|
Invention
|
Reovirus for the treatment of cellular proliferative disorders. Methods for treating proliferativ... |
|
|
Invention
|
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus.
The present inv... |
|
2010
|
Invention
|
Adenoviruses mutated in the va genes for cancer treatment.
This invention refers to the use of a... |
|
|
Invention
|
Use of ribozymes in the detection of adventitious agents. The present invention provides a method... |
|
|
Invention
|
Oncolytic viruses as phenotyping agents for neoplasms. The present invention provides a method of... |
|
2009
|
Invention
|
Modulating interstitial pressure and oncolytic viral delivery and distribution.
Provided herein ... |
|
|
Invention
|
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy. Provided herein... |
|
|
Invention
|
Modulating interstitial pressure and oncolytic viral delivery and distribution. Provided he... |
|
|
Invention
|
Modulating interstitial pressure and oncolytic viral delivery and distribution. Provided herein a... |
|
|
Invention
|
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy. Provided... |
|
2008
|
Invention
|
Treatment regime for proliferative disorders.
Provided herein are methods for treating or amelio... |
|
|
Invention
|
Treatment regime for proliferative disorders. Provided herein are methods for treating or amelior... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of cancer. Medical and scientific research n... |
|
2007
|
P/S
|
Pharmaceutical products and preparations; pharmaceutical preparations for use in the treatment of... |
|
|
P/S
|
Housemark for pharmaceutical products used in the treatment of cancer; pharmaceutical preparation... |
|
|
P/S
|
HOUSEMARK FOR PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CA... |
|
1999
|
P/S
|
Pharmaceutical products namely, medicines for the treatment of cancer. |
